Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: Final analyses from a Phase II study

Tetsuhide Ito, Masayuki Tori, Satoshi Hashigaki, Nobuyuki Kimura, Kazuo Sato, Emiko Ohki, Akira Sawaki, Takuji Okusaka

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: Final analyses from a Phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences